1. Home
  2. TOMZ vs HOTH Comparison

TOMZ vs HOTH Comparison

Compare TOMZ & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TOMI Environmental Solutions Inc.

TOMZ

TOMI Environmental Solutions Inc.

HOLD

Current Price

$0.76

Market Cap

12.5M

Sector

Finance

ML Signal

HOLD

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$0.57

Market Cap

11.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOMZ
HOTH
Founded
1979
2017
Country
United States
United States
Employees
N/A
3
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5M
11.7M
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
TOMZ
HOTH
Price
$0.76
$0.57
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
697.8K
299.9K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
13.64
29.69
EPS
N/A
N/A
Revenue
$5,635,927.00
N/A
Revenue This Year
$48.56
N/A
Revenue Next Year
$121.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.49
52 Week High
$1.20
$2.12

Technical Indicators

Market Signals
Indicator
TOMZ
HOTH
Relative Strength Index (RSI) 55.73 31.88
Support Level $0.73 $0.49
Resistance Level $0.81 $0.80
Average True Range (ATR) 0.08 0.04
MACD 0.00 -0.01
Stochastic Oscillator 58.58 15.87

Price Performance

Historical Comparison
TOMZ
HOTH

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. The product portfolio of the company includes The SteraPak, The Surface Unit, SteraMist Transport, The NV+, The Environment System, and others.

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA). Its current assets are focused in treating cancer, skin toxicities, Alzheimer's, and weight loss.

Share on Social Networks: